Germany's Symrise Q3 organic sales rise 5.3% on higher volumes

By Reuters News


Overview

  • Germany flavors and fragrances supplier's Q3 organic sales grew 5.3%, group sales rose yr/yr

  • Company repurchased 4.3 mln shares as part of ongoing buyback program

  • Company reaffirmed full-year 2026 outlook for organic sales growth and EBITDA margin


Outlook

  • Symrise reaffirms 2026 organic sales growth guidance of 2% to 4%

  • Company expects 2026 adjusted EBITDA margin of 21.5% to 22.5%

  • Company expects Q4 sales growth to moderate sequentially from Q3 due to tougher comparables


Result Drivers

  • VOLUME-DRIVEN GROWTH - Co said Q3 sales growth was mainly driven by higher volumes, supported by solid customer demand and favorable year-on-year comparables

  • REGIONAL MOMENTUM - Double-digit growth in Asia Pacific and strong growth in Latin America contributed to overall sales performance

  • SEGMENT PERFORMANCE - Food & Beverage, Naturals, and Aroma Molecules divisions saw notable organic sales growth


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

9M Revenue

EUR 3.85 bln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy", 6 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the specialty chemicals peer group is "buy"

  • Wall Street's median 12-month price target for Symrise AG is €100.00, about 0% below its October 27 closing price of €100.05

  • The stock recently traded at 23 times the next 12-month earnings vs. a P/E of 21 three months ago


Reuters Recommended Reads

  • Oct 28 - Germany's BASF raises core profit outlook again after quarterly beat

  • Oct 27 - Beiersdorf Q3 sales slightly miss expectations as Nivea weakness persists

  • Oct 26 - France's MEMSCAP Q3 revenue rises on medical and aerospace strength


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.